Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third View: Getting a fresh look at Ocular's axitinib ahead of its wet amd phase 3 data readout

Ticker(s): OCUL

Who's the expert?

Institution: Retina-Vitreous Associates Medical Group

Clinician at Retina-Vitreous Associates Medical Group
Manages over 100+ patients with wet-AMD
Currently a leading investigator for various national clinical trials on retinal diseases and serves as an adviser for multiple research, educational and charitable institutions

Interview Goal

This call will discuss the current treatment landscape and the potential of axitinib, a hydrogel being developed by Ocular for the treatment of wet AMD, including its currently available data.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.